Theodore H. Welling

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.2K citations · Full text

Hepatology, Medicine, Expansion Trial +9

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally, Miruna Balasundaram, Rebecca Carlsen et al. · Cell · 2017 · 2.5K citations · Full text

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

Ilona Kryczek, Mousumi Banerjee, Pui Cheng et al. · Blood · 2009 · 792 citations · Full text

Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells

Shanshan Wan, Ende Zhao, Ilona Kryczek et al. · Gastroenterology · 2014 · 661 citations · Full text

Inflammation, Cytokine, Cancer Immunosurveillance +9

Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis

Ilona Kryczek, Allen T. Bruce, Jóhann E. Guðjónsson et al. · The Journal of Immunology · 2008 · 454 citations · Full text